Baron Wealth Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
Baron Wealth Management's EBS Position: Q3 2026 in Review
Baron Wealth Management sold out of Emergent Biosolutions (EBS) in Q3 2026, closing a stake of 16,239 shares — an estimated $136K sold.
Baron Wealth Management first reported a position in EBS in Q4 2025 and held it in 3 quarters. The position peaked at $136K in Q2 2026. 187 funds tracked by Wall St. Rank hold EBS as of Q3 2026.
- Baron Wealth Management reported no remaining Emergent Biosolutions position as of Q3 2026 after selling out during the quarter.
- Baron Wealth Management sold 16,239 Emergent Biosolutions shares in Q3 2026, an estimated $136K.
- Baron Wealth Management first reported a position in Emergent Biosolutions in Q4 2025 and held it in 3 quarters.
- Baron Wealth Management's Emergent Biosolutions position peaked at $136K in Q2 2026.
- 187 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.
Based on Baron Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.